28-29 November 2019
Hilton, Leeds



Lundbeck is a global pharmaceutical company highly committed to improving the quality of life for people living with brain diseases, with a focus on developing new treatments for psychiatric and neurological disorders.

Lundbeck is a fully-integrated pharmaceutical company, which means that we develop new treatments from the point of discovering a promising new molecule, all the way through the development process to regulatory approval, manufacture and distribution.

Currently we work with NHS organisations across the UK to help support local NHS objectives and improvements in the care and management of patients suffering from psychiatric disorders.

You may also be interested in

By continuing to use the site you agree to our cookies policy. Accept